Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom

BACKGROUND: The prognosis for hepatocellular carcinoma (HCC) is dependent upon tumour stage, performance status (PS), severity of underlying liver disease, and the availability of appropriate therapies. The unavailability of sorafenib may have a significantly adverse effect on the prognosis of UK pa...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Palmer, D H, Hussain, S A, Smith, A J, Hargreaves, S, Ma, Y T, Hull, D, Johnson, P J, Ross, P J
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2013
Ämnen:
Clinical Study
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3749577/
https://ncbi.nlm.nih.gov/pubmed/23880824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.410
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk